EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY - bashrep.elpub.ru

расширенный поиск

EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY

Publication date: 2016

Abstract:

OPKO Biologics is developing bio-better long-acting versions of existing therapeutic proteins utilizing a technology called CTP.

Keywords:
Efficacy of Once-Weekly Administration, CTP-Modified Human Growth Hormone

Тип: Article

DOI: 10.3252/pso.eu.55ESPE.2016